Cite
MLA Citation
Kei Nakashima et al.. “Immunogenicity and safety of COVID-19 vaccine in lung cancer patients receiving anticancer treatment: A prospective multicenter cohort study.” Human vaccines & immunotherapeutics, vol. 18, no. 6, 2022, p. . http://access.bl.uk/ark:/81055/vdc_100172115198.0x000007